4.5 Review

Circulating endothelial progenitor cells: Do they live up to their name?

Journal

VASCULAR PHARMACOLOGY
Volume 67-69, Issue -, Pages 2-5

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.vph.2015.02.018

Keywords

Endothelial progenitor cells; Biomarker; Atherosclerosis; Neovascularization; Tissue ischemia

Funding

  1. Italian Ministry of University and Scientific Research (PRIN) [2010YK7Z5K]
  2. Cariplo Foundation [2011-0566]
  3. Istituto Nazionale Ricerche Cardiovascolari (INRC)

Ask authors/readers for more resources

Preclinical and clinical studies have suggested that specific subsets of cells isolated from the bone marrow or peripheral blood, collectively named endothelial progenitor cells (EPCs), play an essential role in neovascularization and are biomarkers of atherosclerosis, inversely related to the presence and progression of the disease. Conclusive evidence for both the pathophysiological and the biomarker role of these cells is, however, missing, with lack of a unique and universally accepted interpretation for their role, and the absence of general agreement to prompt their use by the practicing clinician. In fact, the engraftment of EPCs after injection into ischemic areas is poor, their secretome is still largely unknown, and there are still many confounding factors such as co-morbidities and medications that limit their use as a faithful biomarker of disease. Here we briefly review the literature on EPCs and discuss their significance in cardiovascular disease both as mediators and as biomarkers, including current methods for their identification. (C) 2015 Elsevier Inc All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Cardiac & Cardiovascular Systems

Circadian rhythms in ischaemic heart disease: key aspects for preclinical and translational research: position paper of the ESC working group on cellular biology of the heart

Sandrine Lecour, Bastiaan C. Du Pre, Hans Erik Botker, Bianca J. J. M. Brundel, Andreas Daiber, Sean M. Davidson, Peter Ferdinandy, Henrique Girao, Can Gollmann-Tepekoeylu, Mariann Gyoengyoesi, Derek J. Hausenloy, Rosalinda Madonna, Michael Marber, Cinzia Perrino, Maurizio Pesce, Rainer Schulz, Joost P. G. Sluijter, Sabine Steffens, Sophie Van Linthout, Martin E. Young, Linda W. Van Laake

Summary: Circadian rhythms play a crucial role in cardiovascular diseases and should be considered as a key research parameter to improve understanding of cardiac physiology/pathology and enhance the translation and efficacy of cardiac therapies. The aim is to highlight key aspects of circadian rhythms for the improvement of preclinical and translational studies related to ischemic heart disease and cardioprotection, which may lead to better clinical outcomes.

CARDIOVASCULAR RESEARCH (2022)

Review Cardiac & Cardiovascular Systems

Animal models and animal-free innovations for cardiovascular research: current status and routes to be explored. Consensus document of the ESC Working Group on Myocardial Function and the ESC Working Group on Cellular Biology of the Heart

Jolanda van der Velden, Folkert W. Asselbergs, Jeroen Bakkers, Sandor Batkai, Luc Bertrand, Connie R. Bezzina, Ilze Bot, Bianca J. J. M. Brundel, Lucie Carrier, Steven Chamuleau, Michele Ciccarelli Dana Dawson, Sean M. Davidson, Andreas Dendorfer, Dirk J. Duncker, Thomas Eschenhagen, Larissa Fabritz, Ines Falcao-Pires, Peter Ferdinandy, Mauro Giacca, Henrique Girao, Can Gollmann-Tepekoeylue, Mariann Gyongyosi, Tomasz J. Guzik, Nazha Hamdani, Stephane Heymans, Andres Hilfiker, Denise Hilfiker-Kleiner, Alfons G. Hoekstra, Jean-Sebastien Hulot, Diederik W. D. Kuster, Linda W. van Laake, Sandrine Lecour, Tim Leiner, Wolfgang A. Linke, Joost Lumens, Esther Lutgens, Rosalinda Madonna, Lars Maegdefessel, Manuel Mayr, Peter van der Meer, Robert Passier, Filippo Perbellini, Cinzia Perrino, Maurizio Pesce, Silvia Priori, Carol Ann Remme, Bodo Rosenhahn, Ulrich Schotten, Rainer Schulz, Karin R. Sipido, Joost P. G. Sluijter, Frank van Steenbeek, Sabine Steffens, Cesare M. Terracciano, Carlo Gabriele Tocchetti, Patricia Vlasman, Kak Khee Yeung, Serena Zacchigna, Dayenne Zwaagman, Thomas Thum, Michele Ciccarelli

Summary: Cardiovascular diseases are a major cause of illness and death, and research is needed to improve diagnostics and discover new preventive and curative therapies. Translating basic science to clinical practice is challenging for complex conditions like cardiovascular diseases, which are often caused by multiple risk factors and comorbidities. Animal models play a vital role in providing important pathophysiological insights into disease mechanisms, particularly on an organ and systemic level.

CARDIOVASCULAR RESEARCH (2022)

Review Cardiac & Cardiovascular Systems

Immune cells in cardiac homeostasis and disease: emerging insights from novel technologies

Sabine Steffens, Matthias Nahrendorf, Rosalinda Madonna

Summary: The use of single-cell immune profiling and advanced microscopic imaging technologies has enhanced our understanding of the cardiac immune system and its role in cardiac diseases.

EUROPEAN HEART JOURNAL (2022)

Article Cell Biology

Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model

Rosalinda Madonna, Damiana Pieragostino, Maria Concetta Cufaro, Piero Del Boccio, Angela Pucci, Letizia Mattii, Vanessa Doria, Christian Cadeddu Dessalvi, Riccardo Zucchi, Giuseppe Mercuro, Raffaele De Caterina

Summary: Ponatinib, a tyrosine kinase inhibitor used in chronic myeloid leukaemia, has been shown to have cardiovascular toxicity. This study investigated the mechanisms of sex-related Ponatinib-induced cardiotoxicity and identified rescue strategies using a mouse model. The results demonstrated sex-related differences in the cardiotoxicity of Ponatinib and the involvement of sex hormones.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

Article Pharmacology & Pharmacy

Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy

Rosalinda Madonna, Serena Barachini, Stefania Moscato, Chiara Ippolito, Letizia Mattii, Chiara Lenzi, Carmela Rita Balistreri, Riccardo Zucchi, Raffaele De Caterina

Summary: This study investigated the effects of SGLT2 inhibitors on PON-induced endothelial cell toxicity. The results showed that EMPA and DAPA could reverse the effects of PON on cell viability, cell senescence, and cell tubulization, thereby attenuating PON-induced vascular toxicity.

VASCULAR PHARMACOLOGY (2022)

Review Cardiac & Cardiovascular Systems

Long COVID and the cardiovascular system-elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases

Mariann Gyongyosi, Pilar Alcaide, Folkert W. Asselbergs, Bianca J. J. M. Brundel, Giovanni G. Camici, Paula da Costa Martins, Peter Ferdinandy, Marianna Fontana, Henrique Girao, Massimiliano Gnecchi, Can Gollmann-Tepekoylu, Petra Kleinbongard, Thomas Krieg, Rosalinda Madonna, Melanie Paillard, Antonis Pantazis, Cinzia Perrino, Maurizio Pesce, Gabriele G. Schiattarella, Joost P. G. Sluijter, Sabine Steffens, Carsten Tschope, Sophie Van Linthout, Sean M. Davidson

Summary: Long COVID is a global non-communicable epidemic characterized by long-lasting multiorgan symptoms after SARS-CoV-2 infection has subsided. This scientific document aims to provide insight into the cardiovascular manifestations of long COVID and the possible causes and therapeutic options available. Imaging has shown evidence of chronic perimyocarditis, arterial wall inflammation, and microthrombosis in certain patient populations. Understanding the underlying cellular and molecular mechanisms is crucial for the development of effective treatment strategies. However, current biomarkers are not highly predictive for the presence or outcome of long COVID.

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Medicine, General & Internal

Exploring Enhanced Cell-Based Therapy for Ischemic Heart Disease and Heart Failure

Rosalinda Madonna

JOURNAL OF CLINICAL MEDICINE (2022)

Review Cardiac & Cardiovascular Systems

Percutaneous treatment of a CTO in an anomalous right coronary artery: A rupture paved the way for new insights

Nino Cocco, Rosalinda Madonna, Valeria Cammalleri, Giulio Cocco, Domenico De Stefano, Danilo Ricciardi, Francesco Grigioni, Gian Paolo Ussia

Summary: Anomalous aortic origin of a coronary artery (AAOCA) is associated with an increased risk of myocardial ischemia and sudden death. The exact pathophysiology of AAOCA is not well understood, leading to a lack of well-defined clinical management. With the increased use of non-invasive imaging, the diagnosis of AAOCA is increasing and the association with atherosclerotic diseases is becoming more important.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy

Rosalinda Madonna, Stefania Moscato, Maria Concetta Cufaro, Damiana Pieragostino, Letizia Mattii, Piero Del Boccio, Sandra Ghelardoni, Riccardo Zucchi, Raffaele De Caterina

Summary: This study found that empagliflozin can inhibit excessive autophagy in the heart of diabetic patients by suppressing the AMPK/GSK3β signaling pathway, thus protecting the heart from damage.

CARDIOVASCULAR RESEARCH (2023)

Editorial Material Medicine, General & Internal

Pulmonary Arterial Hypertension in Genetic and Comorbid Settings: A Step Forward for Precision Medicine

Rosalinda Madonna

JOURNAL OF CLINICAL MEDICINE (2022)

Article Medicine, General & Internal

Impact of Exercise-Induced Pulmonary Hypertension on Right Ventricular Function and on Worsening of Cardiovascular Risk in HIV Patients

Rosalinda Madonna, Lorenzo Ridolfi, Riccardo Morganti, Filippo Biondi, Silvia Fabiani, Arianna Forniti, Riccardo Iapoce, Raffaele De Caterina

Summary: This study investigated the prognostic significance of exercise-induced pulmonary hypertension (ExPH) in HIV-affected patients and found that ExPH may predict an increasing trend of cardiovascular risk over time in these patients.

JOURNAL OF CLINICAL MEDICINE (2022)

Article Pharmacology & Pharmacy

Biobanks: The unmet need in heart failure management

Giovanna Manzi, Marco Valerio Mariani, Domenico Filomena, Roberto Poscia, Paolo Severino, Antonio Iaconelli, Tommaso Recchioni, Rosalinda Madonna, Carmine Dario Vizza, Roberto Badagliacca

Summary: Heart failure (HF) is a significant health and economic issue, and current therapeutic approaches are ineffective due to the complexity of the syndrome. The European Union is developing policies to shift towards precision medicine and identify specific disease biomarkers for targeted therapies. The establishment of biobanks could revolutionize HF treatment by providing a collection of human biological materials and associated data for personalized approaches and research projects.

VASCULAR PHARMACOLOGY (2023)

Review Medicine, General & Internal

Vascular Progenitor Cells: From Cancer to Tissue Repair

Serena Barachini, Sandra Ghelardoni, Rosalinda Madonna

Summary: Vascular progenitor cells are activated to repair and form a neointima following various vascular damages. They not only play a role in resolving vascular lesions, but also contribute to neovascularization and angiogenesis associated with cancer. This review discusses the biology and pathophysiology of vascular progenitor cells, including their origins, stimuli, and activated pathways. It focuses on their involvement in tumor-induced vascular injury and their implications in promoting tumor angiogenesis during cancer proliferation and migration.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Cell Biology

Autophagy, innate immunity, and cardiac disease

Donato Santovito, Sabine Steffens, Serena Barachini, Rosalinda Madonna

Summary: Autophagy is a cellular mechanism that helps cells adapt to metabolic and environmental stress. It plays a crucial role in clearing protein aggregates and dysfunctional organelles, and recent studies have shown its broader role in various pathophysiological conditions. Basal autophagy is essential for maintaining cardiac homeostasis and protecting against age-related cell damage and genomic instability. Additionally, autophagy is stimulated in response to cardiac injuries such as ischemia, pressure overload, and metabolic stress. It also affects the function of neutrophils and other immune cells.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)

Article Pharmacology & Pharmacy

Antineoplastic drugs inducing cardiac and vascular toxicity - An update

Serena Barachini, Sandra Ghelardoni, Zoltan V. Varga, Radwa A. Mehanna, Maria Magdalena Montt-Guevara, Peter Ferdinandy, Rosalinda Madonna

Summary: With the improvement in cancer prognosis, there has been an increase in survival rate among cancer survivors. However, the use of anti-neoplastic drugs has led to an increase in morbidity among these survivors due to cardiovascular complications. These complications include arrhythmias, myocardial ischemia, heart failure, arterial hypertension, thromboembolic events, and accelerated atherosclerosis. The drugs not only target cancer cells but also affect normal cells within the cardiovascular system, leading to toxicity.

VASCULAR PHARMACOLOGY (2023)

No Data Available